The National Pharmaceutical Association, Inc – Trademark Portfolio
Entity Type: 03
The National Pharmaceutical Association, Inc holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 4 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include NPHA, SNPHA, NATIONAL PHARMACEUTICAL ASSOCIATION, and STUDENT NATIONAL PHARMACEUTICAL ASSOCIATION. The owner is based in Phoenix, AZ.
Ste 102-965
10810 North Tatum Blvd.
Phoenix, AZ 85028
Showing of trademarks Trademarks
Trademark Classifications
The National Pharmaceutical Association, Inc's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Frequently Asked Questions
How many trademarks does The National Pharmaceutical Association, Inc have?
The National Pharmaceutical Association, Inc has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does The National Pharmaceutical Association, Inc file in?
The National Pharmaceutical Association, Inc files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.
What are The National Pharmaceutical Association, Inc's most well-known trademarks?
The National Pharmaceutical Association, Inc's registered trademark portfolio includes well-known marks such as NPHA, SNPHA, NATIONAL PHARMACEUTICAL ASSOCIATION, and STUDENT NATIONAL PHARMACEUTICAL ASSOCIATION. These are among 4 currently registered trademarks in the portfolio.
What is The National Pharmaceutical Association, Inc's trademark registration success rate?
The National Pharmaceutical Association, Inc has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.